Occurrence of Gastrointestinal Adverse Events Upon GLP-1 Receptor Agonist Initiation With Concomitant Metformin Use: A Post Hoc Analysis of LEADER, STEP 2, SUSTAIN 6, and PIONEER 6.
Klara R KleinKim K B ClemmensenEdwin FongSøren OlsenTrine AbrahamsenIldiko LingvayPublished in: Diabetes care (2023)
Concomitant metformin use does not increase occurrence of gastrointestinal symptoms during GLP-1RA initiation or impact GLP-1RA discontinuation.